NASDAQ$PIII

P3 Health Partners Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Headline financials

Total Revenue

$274M

No prior period
EPS (adj)

-$0.25

No prior period
Medical Margin

$24.8M

No prior period
Capital Expenditures

-$877K

No prior period
Free Cash Flow

-$11.5M

No prior period
Net Income

-$10.6M

No prior period
Operating Income

-$52.2M

No prior period
Gross Profit

$274M

No prior period
Cash & Equivalents

$110M

No prior period
Total Assets

$2.36B

No prior period
Stock-Based Comp

$11.7M

No prior period

Revenue & EPS history

P3 Health · Revenue · Quarterly

$274M

Q1 2022
Beat estimate in 8 of 12 quarters(67%)
ActualEstimate

Revenue by segment

P3 Health · $386M total across 2 segments · Q1 2026

  • Capitated Revenue
    $379M
  • Other Revenue
    $6.89M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 17 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-3.8%

Avg return

Earnings day

+1.6%

Avg return

5 days after

-2.0%

Avg return

30 days after

37%

7 / 19 earnings

Positive

+11.2%

Q1 2026

Best reaction

-36.8%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.7%-9.7%
Q1 2026+11.2%+194.4%+239.9%
Q3 2025+0.4%-12.6%-25.9%
Q2 2025-2.5%+5.4%+23.9%
Q1 2025-0.6%-5.9%-19.5%
Q4 2024-4.5%+1.1%-1.2%
Q3 2024-36.8%-42.2%-46.0%
Q2 2024-2.5%-8.7%-24.1%
Q1 2024+2.6%-11.8%-21.6%
Q4 2023-13.3%-22.4%-56.3%
Q4 2021+3.1%-7.6%-12.2%
Q3 2023-2.1%-8.8%-19.0%
Q2 2023+0.9%-10.8%-5.0%
Q4 2022-5.9%-12.7%+15.5%
Q3 2022-11.8%-19.7%-33.5%
Q1 2022-5.9%+2.1%-16.8%
Q2 2022-4.1%+0.6%-14.0%
Q3 2021+0.1%+0.3%-19.9%
Q2 2021-0.7%-0.2%+0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro